Literature DB >> 14965245

5-ht6 receptors.

Marie L Woolley1, Charles A Marsden, Kevin C F Fone.   

Abstract

The 5-hydroxytryptamine(6) (5-ht(6)) was one of the most recent additions to the 5-HT receptor family, selective antagonists have recently been developed and potential functional roles are now becoming apparent. The high affinity of a wide range of psychiatric drugs for the 5-ht(6)receptor, together with its almost exclusive expression in the CNS, being abundant in limbic and cortical regions, has stimulated significant research interest. The 5-ht(6)receptor appears to regulate glutamatergic and cholinergic neuronal activity, and increasing evidence suggests that it may be involved in the regulation of cognition, feeding and, possibly, affective state and seizures. The current article will review all aspects of the discovery, genetics, distribution, pharmacology and function of the 5-ht(6)receptor. Taken together, this wealth of information warrants the use of the upper case nomenclature for the 5-ht(6) receptor to be approved and its true status recognised.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14965245     DOI: 10.2174/1568007043482561

Source DB:  PubMed          Journal:  Curr Drug Targets CNS Neurol Disord        ISSN: 1568-007X


  63 in total

Review 1.  PET tracers for serotonin receptors and their applications.

Authors:  J S Dileep Kumar; J John Mann
Journal:  Cent Nerv Syst Agents Med Chem       Date:  2014

2.  Biodistribution and radiation dosimetry of the serotonin 5-HT₆ ligand [¹¹C]GSK215083 determined from human whole-body PET.

Authors:  Robert A Comley; Cristian Salinas; Romina Mizrahi; Irina Vitcu; Alvina Ng; William Hallett; Nicholas Keat; Alan A Wilson; Eugenii A Rabiner; Marc Laruelle; Sylvain Houle
Journal:  Mol Imaging Biol       Date:  2012-08       Impact factor: 3.488

3.  Peptides derived from the third cytoplasmic loop of type 6 serotonin receptor as regulators of serotonin-sensitive adenylyl cyclase signaling system.

Authors:  A O Shpakov; I I Tarasenko; E A Shpakova
Journal:  Dokl Biochem Biophys       Date:  2010 Mar-Apr       Impact factor: 0.788

4.  Selective serotonin receptor stimulation of the medial nucleus accumbens differentially affects appetitive motivation for food on a progressive ratio schedule of reinforcement.

Authors:  Wayne E Pratt; Megan A Schall; Eugene Choi
Journal:  Neurosci Lett       Date:  2012-01-24       Impact factor: 3.046

Review 5.  Serotonergic modulation of hippocampal theta activity in relation to hippocampal information processing.

Authors:  María Esther Olvera-Cortés; Blanca Erika Gutiérrez-Guzmán; Elisa López-Loeza; J Jesús Hernández-Pérez; Miguel Angel López-Vázquez
Journal:  Exp Brain Res       Date:  2013-08-30       Impact factor: 1.972

Review 6.  Serotonergic drugs : effects on appetite expression and use for the treatment of obesity.

Authors:  Jason C G Halford; Joanne A Harrold; Emma J Boyland; Clare L Lawton; John E Blundell
Journal:  Drugs       Date:  2007       Impact factor: 9.546

7.  Activation of 5-HT(6) receptors facilitates attentional set shifting.

Authors:  Katherine E Burnham; Mark G Baxter; John R Bainton; Eric Southam; Lee A Dawson; David M Bannerman; Trevor Sharp
Journal:  Psychopharmacology (Berl)       Date:  2009-11-10       Impact factor: 4.530

8.  Increased impulsivity and disrupted attention induced by repeated phencyclidine are not attenuated by chronic quetiapine treatment.

Authors:  Nurith Amitai; Athina Markou
Journal:  Pharmacol Biochem Behav       Date:  2008-09-08       Impact factor: 3.533

Review 9.  The role of serotonin in memory: interactions with neurotransmitters and downstream signaling.

Authors:  Mohammad Seyedabadi; Gohar Fakhfouri; Vahid Ramezani; Shahram Ejtemaei Mehr; Reza Rahimian
Journal:  Exp Brain Res       Date:  2014-01-16       Impact factor: 1.972

10.  Binding of serotonin and N1-benzenesulfonyltryptamine-related analogs at human 5-HT6 serotonin receptors: receptor modeling studies.

Authors:  Małgorzata Dukat; Philip D Mosier; Renata Kolanos; Bryan L Roth; Richard A Glennon
Journal:  J Med Chem       Date:  2008-01-18       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.